Heather Trilles is a seasoned biotech leader with over 20 years of experience spanning the entire drug development lifecycle, from preclinical research through to successful product launch. As the Head of Commercial and Executive Director of New Product Planning & Strategic Insights at Enanta Pharmaceuticals,...
Heather Trilles is a seasoned biotech leader with over 20 years of experience spanning the entire drug development lifecycle, from preclinical research through to successful product launch. As the Head of Commercial and Executive Director of New Product Planning & Strategic Insights at Enanta Pharmaceuticals, Heather plays a pivotal role in shaping the company's strategic direction and commercial success. Her deep expertise in small molecule and RNA-targeted therapies, particularly for rare diseases, allows her to leverage a robust scientific background alongside her extensive commercial experience.
In her current role, Heather has been instrumental in embedding a commercial perspective into the decision-making processes for both preclinical and clinical portfolios. This strategic approach has been crucial in guiding Enanta's expansion into the immunology space, ensuring that the company is well-positioned to meet evolving market demands. One of her key achievements includes leading the commercial activities that enabled the successful monetization of MAVYRET royalties, generating an impressive $200 million in revenue.
Heather's proficiency in marketing strategy, data analysis, and product launch is complemented by her ability to lead cross-functional teams effectively. She excels in aligning diverse stakeholders around a common vision, driving business strategy, and enhancing market access. Her commitment to fostering innovation and her keen insights into market dynamics make her a valuable asset to Enanta Pharmaceuticals and the broader biotech community. With a focus on delivering impactful therapies, Heather continues to champion initiatives that enhance patient outcomes while maximizing portfolio and program value.
